Get the Stockscreener App
7.062
0.78%
0.062
Teladoc Health Inc stock is traded at $7.062, with a volume of 2.22M.
It is up +0.78% in the last 24 hours and down -5.94% over the past month.
Teladoc Health Inc is engaged in virtual care, forging a new healthcare experience with improved convenience, outcomes, and value. Its mission is to empower all people everywhere to live their healthiest lives by transforming the healthcare experience. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems.
See More
Previous Close:
$7.00
Open:
$7
24h Volume:
2.22M
Relative Volume:
0.32
Market Cap:
$1.25B
Revenue:
$2.54B
Net Income/Loss:
$-207.36M
P/E Ratio:
-5.9345
EPS:
-1.19
Net Cash Flow:
$151.25M
1W Performance:
-0.92%
1M Performance:
-5.94%
6M Performance:
-15.52%
1Y Performance:
-25.90%
1-Day Range:
$6.96
$7.12
1-Week Range:
$6.88
$7.15
52-Week Range:
$6.35
$15.21
Teladoc Health Inc Stock (TDOC) Company Profile
Name
Teladoc Health Inc
Sector
Industry
Phone
(203) 635-2002
Address
155 E 44TH STREET, NEW YORK, NY
Compare TDOC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TDOC
Teladoc Health Inc
|
7.055 | 1.24B | 2.54B | -207.36M | 151.25M | -1.19 |
|
VEEV
Veeva Systems Inc
|
220.28 | 36.69B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
61.68 | 10.51B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
43.87 | 8.34B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
91.91 | 7.83B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
37.91 | 6.75B | 11.99B | 24.18M | 234.31M | 0.2956 |
Teladoc Health Inc Stock (TDOC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Equal Weight |
| Nov-13-25 | Initiated | BMO Capital Markets | Market Perform |
| Jul-25-25 | Initiated | Mizuho | Neutral |
| Nov-15-24 | Initiated | Goldman | Buy |
| Sep-17-24 | Reiterated | Jefferies | Hold |
| Feb-29-24 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-17-24 | Downgrade | DA Davidson | Buy → Neutral |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Feb-23-23 | Upgrade | SVB Securities | Market Perform → Outperform |
| Oct-24-22 | Upgrade | Guggenheim | Sell → Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-07-22 | Initiated | Truist | Hold |
| Aug-17-22 | Downgrade | Guggenheim | Neutral → Sell |
| Aug-12-22 | Initiated | DA Davidson | Buy |
| Aug-02-22 | Downgrade | Berenberg | Buy → Hold |
| Aug-02-22 | Downgrade | Cowen | Outperform → Market Perform |
| Jul-28-22 | Downgrade | Goldman | Buy → Neutral |
| Jul-28-22 | Downgrade | Needham | Buy → Hold |
| Jul-06-22 | Reiterated | BofA Securities | Neutral |
| May-05-22 | Downgrade | Argus | Buy → Hold |
| Apr-28-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-28-22 | Downgrade | Credit Suisse | Outperform → Neutral |
| Apr-28-22 | Downgrade | Guggenheim | Buy → Neutral |
| Apr-28-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Apr-28-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-28-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-28-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-07-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-03-22 | Upgrade | Argus | Hold → Buy |
| Feb-23-22 | Reiterated | BofA Securities | Neutral |
| Feb-23-22 | Reiterated | Craig Hallum | Hold |
| Feb-23-22 | Reiterated | Evercore ISI | In-line |
| Feb-23-22 | Reiterated | Goldman | Buy |
| Feb-23-22 | Reiterated | JP Morgan | Overweight |
| Feb-23-22 | Reiterated | KeyBanc Capital Markets | Overweight |
| Feb-23-22 | Reiterated | Needham | Buy |
| Feb-23-22 | Reiterated | Oppenheimer | Outperform |
| Feb-23-22 | Reiterated | Stifel | Hold |
| Feb-11-22 | Initiated | Goldman | Buy |
| Feb-08-22 | Reiterated | Piper Sandler | Overweight |
| Dec-02-21 | Resumed | Jefferies | Hold |
| Nov-22-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-28-21 | Reiterated | Barclays | Equal Weight |
| Oct-28-21 | Reiterated | BofA Securities | Neutral |
| Oct-28-21 | Reiterated | Canaccord Genuity | Buy |
| Oct-28-21 | Reiterated | Citigroup | Buy |
| Oct-28-21 | Reiterated | Craig Hallum | Hold |
| Oct-28-21 | Reiterated | Needham | Buy |
| Oct-28-21 | Reiterated | Oppenheimer | Outperform |
| Oct-28-21 | Reiterated | Piper Sandler | Overweight |
| Oct-28-21 | Reiterated | UBS | Neutral |
| Oct-19-21 | Initiated | Wells Fargo | Overweight |
| Aug-02-21 | Downgrade | Argus | Buy → Hold |
| Jul-28-21 | Downgrade | Deutsche Bank | Buy → Hold |
| May-28-21 | Initiated | Robert W. Baird | Neutral |
| Apr-15-21 | Initiated | Needham | Buy |
| Jan-07-21 | Initiated | BTIG Research | Buy |
| Dec-22-20 | Initiated | Evercore ISI | In-line |
| Dec-07-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Dec-04-20 | Initiated | Goldman | Neutral |
| Nov-13-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Sep-22-20 | Initiated | DA Davidson | Buy |
| Sep-02-20 | Upgrade | Berenberg | Hold → Buy |
| Aug-17-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jul-13-20 | Initiated | Argus | Buy |
| Jul-07-20 | Initiated | Stephens | Overweight |
| Apr-30-20 | Reiterated | KeyBanc Capital Markets | Overweight |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Mar-31-20 | Downgrade | Berenberg | Buy → Hold |
| Mar-25-20 | Downgrade | Craig Hallum | Buy → Hold |
| Mar-16-20 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-12-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-28-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-12-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-10-20 | Initiated | UBS | Neutral |
| Jan-09-20 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Teladoc Health Inc Stock (TDOC) Latest News
Is the Market Bullish or Bearish on Teladoc Health Inc? - Benzinga
HIMS Scales AI-Enabled Care as Platform Depth and Engagement Expand - The Globe and Mail
Japan's Telemedicine and AI-Driven Healthcare Adoption Propel - openPR.com
Why Teladoc Health Stock Jumped 15% This Morning - AOL.com
Chegg, Skillz, and Teladoc Shares Plummet, What You Need To Know - Yahoo Finance
(TDOC) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Teladoc Health Buys Catapult Health In $65M Acquisition - MSN
Voya Investment Management LLC Sells 99,728,586 Shares of Teladoc Health, Inc. $TDOC - MarketBeat
Teladoc Health Held In-Line Rating in Late Ocotber as Evercore Reversed Price Target Back to $8 - MSN
Down 98% From Its All-Time High? Is It Finally Time to Buy This Former Market Darling? - Finviz
HIMS vs. TDOC: Which telehealth stock looks more compelling? - MSN
Can Teladoc Health Inc. (4LL) stock sustain margin levelsEarnings Per Share Trends & Affordable Trading Strategies - bollywoodhelpline.com
Teladoc Health (NYSE:TDOC) Stock Crosses Below 50-Day Moving AverageHere's Why - MarketBeat
Teladoc Health Inc. (TDOC): GenAI Advancements Amid Bank of America’s Price Target Adjustment - MSN
Will New Analyst Coverage Shape Teladoc’s Evolving Virtual Care Story for Investors (TDOC)? - Sahm
HIMS vs. TDOC: Which Telehealth Stock Looks More Compelling? - The Globe and Mail
Why Teladoc (TDOC) Stock Is Up Today - Finviz
Can Teladoc Health Inc. stock expand revenue streamsJuly 2025 Drop Watch & Technical Entry and Exit Alerts - DonanımHaber
Teladoc Health Stock Jumps on Barclays Coverage Initiation | Market AnalysisNews and Statistics - IndexBox
Barclays Initiates Coverage on Teladoc (TDOC) with Equal Weight at $8.50 - Finviz
Virtual Care Market to Reach US$ 72.73 Billion by 2033 at 13.2% - openPR.com
11 Best Healthcare AI Stocks to Buy Now - Insider Monkey
Earnings Beat: How geopolitical tensions affect Teladoc Health Inc. stockBond Market & Weekly Setup with High ROI Potential - moha.gov.vn
Will Teladoc Health Inc. stock return to pre crisis levelsTrade Entry Summary & Accurate Trade Setup Notifications - ulpravda.ru
Why Teladoc Health Inc. stock is favored by pension funds2025 Performance Recap & Expert Curated Trade Ideas - ulpravda.ru
Will Teladoc Health Inc. stock recover faster than market2025 Retail Activity & Low Risk High Win Rate Stock Picks - Улправда
Why Teladoc Health Inc. stock is popular among millennialsJuly 2025 Update & Capital Protection Trade Alerts - Улправда
Responsive Playbooks and the TDOC Inflection - news.stocktradersdaily.com
Teladoc Health, Inc. (NYSE:TDOC) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Online Doctor Consultation Market to Reach US$ 47.29 Billion - openPR.com
Teladoc Board Member J. Eric Evans to Retire - TipRanks
Teladoc Health Announces Board Retirement - TradingView — Track All Markets
Teladoc board member Evans to retire in 2026 - StreetInsider
Teladoc Health, Inc. Announces Retirement of J. Eric Evans as Director - marketscreener.com
Teladoc Health (TDOC): Revisiting Valuation After a Modest One-Month Share Price Rebound - Yahoo Finance
Teladoc Health, Inc.'s (NYSE:TDOC) Recent 4.7% Pullback Adds to One-year Year Losses, Institutional Owners May Take Drastic Measures - 富途牛牛
Forget Teladoc and buy this healthcare stock instead - MSN
Teladoc Health Earnings Notes - Trefis
TDOC (Teladoc Health) Days Inventory : 19.03 (As of Sep. 2025) - GuruFocus
Forget Teladoc and Buy This Healthcare Stock Instead - sharewise.com
Teladoc Health (NYSE:TDOC) CEO Charles Divita III Sells 17,138 Shares - MarketBeat
Teladoc Amends Incentive Plan to Increase Shares - TipRanks
Top Telemedicine Services for Hospitals: Leading Solutions Compared - MedCity News
Maple Rock Capital Partners Inc. Sells 659,062 Shares of Teladoc Health, Inc. $TDOC - MarketBeat
United States Telestroke Services Market to Reach USD 5.16 - openPR.com
Will Barclays’ Equal-Weight Initiation Reframe Teladoc’s (TDOC) Virtual Care Risk‑Reward Narrative? - Sahm
Teladoc Health CEO Charles Divita III Sells Shares to Cover Tax Obligations - TradingView — Track All Markets
Teladoc Health (NYSE: TDOC) CEO reports RSU vesting and tax-related sale - Stock Titan
CEO Divita III Files To Sell 17,138 Of Teladoc Health Inc [TDOC] - TradingView — Track All Markets
Hims & Hers Expands Its Technology-Driven Personalized Virtual Care - The Globe and Mail
Teladoc Health (NYSE:TDOC) Stock Rating Upgraded by Barclays - MarketBeat
Teladoc Health Inc Stock (TDOC) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.25%
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):